Cambridge Cognition and ActiGraph partner to advance digital health technologies in CNS trials
LONDON, UK: Cambridge Cognition Holdings plc, a developer and marketer of digital solutions for brain health assessment, has announced a new strategic partnership with ActiGraph,...
Saama and Pfizer expand AI partnership to accelerate clinical trials
Saama, a leading provider of AI-based solutions for clinical development and commercialization, announced a new multi-year agreement with Pfizer, a global biopharmaceutical company, to scale...
MGC Pharma to acquire Israel based MediCaNL for $6.0 million in shares
LONDON: MGC Pharmaceuticals Ltd announced the acquisition of 100% of the issued share capital of MediCaNL Inc. MediCaNL Inc is the holding company of MediCaNL...
UK begins clinical trials of Covid-busting nasal spray
LONDON: The first UK clinical trials of a nasal spray proven to kill 99.9% of the coronavirus that causes Covid-19 will begin on January 11th...
AstraZeneca selects ImpediMed’s SOZO devices for upcoming clinical trials
BRISBANE: ImpediMed Limited announced a second contract valued at over $2.0 million for its SOZO Digital Health Platform to be used in a clinical trial...
AstraZeneca’s COVID-19 long-acting antibody combination advances into Phase III clinical trials
LONDON: AstraZeneca’s long-acting antibody (LAAB) combination, AZD7442, will advance into two Phase III clinical trials in more than 6,000 participants at sites in and outside...